Clinical Trial to Evaluate the Efficacy of Neuromuscular Electrical Stimulation Therapy in Patients With Sarcopenia

Sponsor
Exosystems
Study ID
NCT07668258
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Sarcopenia

Eligibility Criteria

Sex
ALL
Age
50 Years - 85 Years
Healthy Volunteers
Not accepted

Interventions

  • neuromuscular electrical stimulation — DEVICE
    once daily, for at least 20 minutes per session, at least 4 times per week, over the 8-week study period

Study Details

The goal of this clinical trial is to exploratorily evaluate the safety and efficacy of a home-based lower extremity muscle strengthening and physical performance enhancement program using Neuromuscular Electrical Stimulation (NMES) devices. Participants will apply NMES stimulation to both thighs for 8 weeks, at a frequency of at least 4 times per week.

Key Dates

First listed
Jun 25, 2026
Start date
Jun 9, 2026
Status verified
Jun 2026
Primary completion
Dec 31, 2026
Completion
Feb 28, 2027

Study Design

Enrollment
40 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: NMES Treatment Group
    electrical stimulation with an exercise therapy program
  • Sham Comparator: Control Group
    minimal perceptible level electrical stimulation with an exercise therapy program

Primary Outcome Measure

Change in muscle mass [ Time Frame: from baseline to Week 8. ]

Central Contacts

Related Studies